Buffer Preparation Market Trends & Forecasts Report 2025-2035 Featuring Asahi Kasei, Avantor, Canvax, Danaher, GE, HOPAX, Merck, Prepared Biologics, Sartorius, Sepragen, Thermo Fisher Scientific, ZETA

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

• More than 70 companies are offering buffer manufacturing services for different packaging formats; close to 55% of the buffer manufacturing service providers are based in North America

  80% confidence

• 86% of the buffer manufacturing systems are fabricated using stainless steel; 95% of the buffer systems work automatically with various controls for pH, conductivity, temperature and pressure

  80% confidence

• Over 60% of the firms engaged in this domain manufacture custom buffers; most of these buffers have been formulated as liquid bottles

  80% confidence

• Close to 20% of the total partnership deals have been signed in the last two years, showing growing stakeholder interest in buffer manufacturing

  80% confidence

• The antibodies segment is likely to capture the maximum share (~55%) of the overall market

  80% confidence

• The bottles segment captures the majority share (~40%) in the overall market in the current year and is likely to dominate the market in the future

  80% confidence

• The buffer preparation market size is currently valued at USD 8.58 billion and is projected to reach 17.96 billion by 2035, growing at a CAGR of 7.8% during the forecast period

  80% confidence

• The market in Asia-Pacific is likely to grow at a high CAGR (8%), during the forecast period

  80% confidence

• The reusable buffer mixing / preparation equipment market segment is likely to capture the majority share (~80%) in the overall market in the current year and is likely to grow at a relatively faster rate during the forecast period

  80% confidence

• Around 60 buffer manufacturing systems are currently available in the market for stabilizing drug components in biopharmaceuticals; notably, most of these buffer systems are offered by players based in the US

  80% confidence

• The liquid formulations segment is likely to capture the maximum share (~70%) due to liquid buffers providing consistency between batches and minimizing the chance of human mistakes

  80% confidence

• North America is likely to capture the majority share (~40%) in the overall market currently, and this trend is unlikely to change in the future

  80% confidence

• The cell and gene therapies segment will grow at a significantly higher CAGR (19.5%) throughout the forecast period

  80% confidence

• The commercial scale segment is likely to capture the maximum share (~85%) and this trend is likely to remain the same in the coming years

  80% confidence

• The small molecules segment is likely to capture the maximum share (~75%) due to the extensive therapeutic potential of small molecules and the rising occurrence of chronic illnesses

  80% confidence